Antimetastatic effect of epigenetic drugs, hydralazine and valproic acid, in Ras-transformed NIH 3T3 cells


Por: Perez-Cardenas, Enrique, Taja-Chayeb, Lucia, Trejo-Becerril, Catalina, Chanona-Vilchis, Jose, Chavez-Blanco, Alma, Dominguez-Gomez, Guadalupe, Langley, Elizabeth, Garcia-Carranca, Alejandro, Duenas-Gonzalez, Alfonso

Publicada: 1 ene 2018
Resumen:
Introduction: Metastasis involves the accumulation of genetic and epigenetic alterations leading to activation of prometastatic genes and inactivation of antimetastatic genes. Among epigenetic alterations, DNA hypermethylation and histone hypoacetylation are the focus of intense translational research because their pharmacological inhibition has been shown to produce antineoplastic activity in a variety of experimental models. Aims: This study aimed to evaluate the antimetastatic effect of the DNA-methylation inhibitor, hydralazine, and the histone deacetylase inhibitor, valproic acid. Methods: NIH 3T3-Ras murine cells were treated with hydralazine and valproic acid to evaluate their effects upon cell proliferation, cell motility, chemotaxis, gelatinase activity, and gene expression. Lung metastases were developed by intravenous injection of NIH 3T3-Ras cells in BALB/c nu/nu mice and then treated with the drug combination. Results: Treatment induced a growth-inhibitory effect on NIH 3T3-Ras cells, showed a trend toward increased gelatinase activity of MMP2 and MMP9, and inhibited chemotaxis and cell motility. The combination led to a strong antimetastatic effect in lungs of nude mice. Conclusion: Hydralazine and valproic acid, two repositioned drugs as epigenetic agents, exhibit antimetastatic effects in vitro and in vivo and hold potential for cancer treatment.

Filiaciones:
Perez-Cardenas, Enrique:
 Inst Nacl Cancerol, Div Basic Res, Mexico City, DF, Mexico

Taja-Chayeb, Lucia:
 Inst Nacl Cancerol, Div Basic Res, Mexico City, DF, Mexico

Trejo-Becerril, Catalina:
 Inst Nacl Cancerol, Div Basic Res, Mexico City, DF, Mexico

Chanona-Vilchis, Jose:
 Inst Nacl Cancerol, Dept Pathol, Mexico City, DF, Mexico

Chavez-Blanco, Alma:
 Inst Nacl Cancerol, Div Basic Res, Mexico City, DF, Mexico

Dominguez-Gomez, Guadalupe:
 Inst Nacl Cancerol, Div Basic Res, Mexico City, DF, Mexico

Langley, Elizabeth:
 Inst Nacl Cancerol, Div Basic Res, Mexico City, DF, Mexico

Garcia-Carranca, Alejandro:
 Univ Nacl Autonoma Mexico, Unit Biomed Res Canc, Biomed Res Inst, Mexico City, DF, Mexico

 Inst Nacl Cancerol, Unit Biomed Res Canc, Mexico City, DF, Mexico

Duenas-Gonzalez, Alfonso:
 Univ Nacl Autonoma Mexico, Unit Biomed Res Canc, Biomed Res Inst, Mexico City, DF, Mexico

 Inst Nacl Cancerol, Unit Biomed Res Canc, Mexico City, DF, Mexico
ISSN: 11786930
Editorial
DOVE MEDICAL PRESS LTD, PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND, Nueva Zelanda
Tipo de documento: Article
Volumen: 11 Número:
Páginas: 8823-8833
WOS Id: 000452770700001
ID de PubMed: 30584338

MÉTRICAS